Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Dunleavy Website

Kieron M. Dunleavy, M.D.

Selected Publications

1)  Roschewski M, Dunleavy K, Wilson WH.
Moving Beyond R-CHOP for Diffuse Large B-cell Lymphoma.
Leuk. Lymphoma. [Epub ahead of print], 2014.
[Journal]
2)  Klion AD, Mejia R, Cowen EW, Dowdell KC, Dunleavy K, Fahle GA, Holland-Thomas N, Maric I, Pittaluga S, Raffeld M, Santos C, Stetler-Stevenson M, Krogmann T, Shatzer AN, Turk SP, Yin Y, Xi L, Prussin C, Cohen JI.
Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.
Blood. 121: 2364-6, 2013.
[Journal]
3)  Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH.
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
N. Engl. J. Med. 368: 1408-16, 2013.
[Journal]
4)  Dunleavy K, Wilson WH.
Implications of the shifting pathobiology of AIDS-related lymphoma.
J. Natl. Cancer Inst. 105: 1170-1, 2013.
[Journal]
5)  Lai C, Grant C, Dunleavy K.
Interpreting MYC and BCL2 in diffuse large B-cell lymphoma.
Leuk. Lymphoma. 54: 2091-2, 2013.
[Journal]
6)  Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH.
Low-intensity therapy in adults with Burkitt"s lymphoma.
N. Engl. J. Med. 369: 1915-25, 2013.
[Journal]
7)  Lai C, Dunleavy K.
NK/T-cell lymphomas in children.
Best Pract Res Clin Haematol. 26: 33-41, 2013.
[Journal]
8)  Dunleavy K, Bollard CM.
Scouting out the neighborhood in AIDS-related lymphoma.
Blood. 122: 306-7, 2013.
[Journal]
9)  Davidson-Moncada JK, Pittaluga S, Roth M, Dunleavy K, Duffy A, Pavletic S.
Second cancers early post allogeneic transplant: the case of "unrestrained" malignancy?.
Bone Marrow Transplant. 48: 872-4, 2013.
[Journal]
10)  Lai C, Dunleavy K.
Tackling Burkitt lymphoma in older patients: novel strategies and the promise of targeted agents.
Leuk. Lymphoma. 54: 443-4, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 2/25/2014.